Perception of risk from tobacco use is lower among cancer survivors who smoke
the ONA take:
A new study identified several factors that inhibit the efforts of cancer survivors who smoke to quit. In the study, cancer survivors who smoke reported fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who quit before or after their diagnosis.
The researchers report that patients with cancers strongly linked to smoking, such as lung and head and neck, had high initial quit rates; however, many relapse and begin smoking again. Quit rates are not high among patients with other cancers. Researchers feel they may not realize the connection between their cancer and smoking, or they did not receive advice or follow-up assistance in regard to smoking cessation.
The analysis also revealed that survivors who currently smoked reported more daily exposure to others who smoke. The researchers say this is a factor that needs to be considered when counseling patients about quitting smoking. They suggest that exposure to other smokers should be addressed when counseling patients with cancer to quit.
A new study identified several factors that inhibit the efforts of cancer survivors who smoke to quit.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
- Increased Diabetes Risk Associated With Cancer Development
- Childhood Neuroblastoma Survivors at Risk for Psych Impairment
- Drug Classification of Trastuzumab
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|